Category: Health
U.S. drugstore owner, Walgreens Boots Alliance Inc. is reportedly in talks with health insurer Humana Inc. as the two companies are contemplating to take over each other’s equity stakes. The deal comes at a time when health-industry players are collaborating to compete in a rapidly …
Eurofins Genomics, a global leader in bioanalytical testing has recently announced plans to collaborate with leading genome engineering products provider Synthego, to distribute sgRNA (synthetic single guide RNA) to the company’s global customer database across 44 countries. CRISPR technology is being accepted by clinical labs …
AstraZeneca, the pharmaceutical firm headquartered in Cambridge, has confirmed the sale of the U.S. rights to Synagis®, which is used for preventing respiratory tract infections, to specialty biopharmaceutical company Sobi AB. The multibillion-dollar deal would also involve nearly 130 workers being transferred to the Swedish …
In a recent clinical trial, AstraZeneca’s diabetes pill Farxiga has reportedly shown positive test results in treating heart failure and reducing the risk of kidney problems in a wide pool of patients. However, as per trusted sources, the medication that belongs to a set of …
Hedge fund Elliot Management and private equity company Veritas Capital have reportedly joined hands to buy the U.S.-based healthcare software manufacturer Athenahealth for USD 5.5 billion in an all-cash deal. As per people familiar with the development, the acquisition is likely to be announced soon. …
U.S. based pharmaceutical company Merck has reportedly launched its BioContinuum Platform in an attempt to advance the production of biotherapeutic drugs through improved efficiency, greater quality and consistency as well as simplified plant operations. This expanded offering was introduced by the company at the 2018 …
Pfizer Inc., the New York-based pharmaceutical company, has reportedly announced that its third-generation lung cancer drug LORBRENA has been approved by the U.S. Food & Drug Administration (FDA). Reports cite, the drug – an ALK TKI (Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor) – is designed …
Biotech firm Illumina, Inc. and rival Pacific Biosciences have announced that they have inked a deal for Illumina to acquire Pacific Biosciences in an all-cash transaction, at a fixed price of $8 per Pacific Biosciences share. Apparently, the price is a 71% premium to weighted …
